Kidney disease increases risk of diabetes, study shows

December 11, 2017

Diabetes is known to increase a person's risk of kidney disease. Now, a new study from Washington University School of Medicine in St. Louis suggests that the converse also is true: Kidney dysfunction increases the risk of diabetes.

Further, the researchers deduced that a likely culprit of the two-way relationship between kidney disease and diabetes is urea. The nitrogen-containing waste product in blood comes from the breakdown of protein in foods. Kidneys normally remove urea from the blood, but it can build up when kidney function slows down.

The findings are significant because urea levels can be lowered through medication, diet -- for example, by eating less protein -- and other means, thereby allowing for improved treatment and possible prevention of diabetes.

The epidemiological study, conducted in collaboration with the Veterans Affairs St. Louis Health Care System, is published Dec. 11 in Kidney International.

"We have known for a long time that diabetes is a major risk factor for kidney disease, but now we have a better understanding that kidney disease, through elevated levels of urea, also raises the risk of diabetes," said the study's senior author Ziyad Al-Aly, MD, an assistant professor of medicine at Washington University. "When urea builds up in the blood because of kidney dysfunction, increased insulin resistance and impaired insulin secretion often result."

In collaboration with scientists at the St. Louis Veterans Affairs' Clinical Epidemiology Center, Washington University researchers examined medical records in national VA databases to dissect the relationship between kidney disease and diabetes. They evaluated the records of 1.3 million adults without diabetes over a five-year period, beginning in 2003.

A common blood test that measures the amount of urea nitrogen found in the blood showed that 117,000 of those without diabetes -- or 9 percent -- had elevated urea levels, signaling poor kidney function.

"That figure -- 9 percent of people with high urea levels -- remained relatively constant over time," Al-Aly said. "It is also reflective of the general population."

Overall, he said, those with high urea levels had a 23 percent higher risk of diabetes -- a figure researchers determined by comparing risk between those with high and low urea levels. In each year studied, the researchers documented new cases of diabetes in 2,989 of every 100,000 people with low urea levels and 3,677 new cases of diabetes among those with high urea levels.

"The risk difference between high and low levels is 688 cases of diabetes per 100,000 people each year," Al-Aly said. "This means that for every 100,000 people, there would be 688 more cases of diabetes each year in those with higher urea levels."

Al-Aly said he was inspired to delve into the relationship between diabetes and kidney disease after reading a mouse study published in the August 2016 Journal of Clinical Investigation. As part of the study, researchers from the University of Montreal Hospital Research Centre in Canada induced kidney failure in mice. Subsequently, many of the animals experienced elevated urea levels, resulting in insulin resistance and impaired insulin secretion.

"I read the study with excitement and intrigue, and I thought, 'We have to test this in humans,' " Al-Aly recalled. "Our results were almost an exact replica of the mouse study. The results showed a clear relationship between urea levels and risk of diabetes."
-end-


Washington University in St. Louis

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.